Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 27, 950-955, May 1, 1967]
© 1967 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sunderman, F. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sunderman, F. W., Jr.

Inhibition of Induction of Benzpyrene Hydroxylase by Nickel Carbonyl1

F. William Sunderman, Jr.

Pathology Department, University of Florida College of Medicine, Gainesville, Florida 32603

Exposure of rats to nickel carbonyl by inhalation (0.2 mg Ni/liter of air/15 min) or intravenous injection (2 mg Ni/100 gm) was found to inhibit the induction of benzpyrene hydroxylase in lung and liver. Phenothiazine induction and fluorometric measurements of benzpyrene hydroxylase were performed by the methods of Wattenberg and co-workers (31, 32). Benzpyrene hydroxylase activities in lungs and livers of control rats were 9.5 (S.D. ± 4.3) and 295 (S.D. ± 123) units, respectively. Benzpyrene hydroxylase activities began to diminish 3 hours after administration of nickel carbonyl, reached a minimum at 2 to 3 days, and remained diminished up to 1 week. For example, 52 hours after injection of nickel carbonyl, benzpyrene hydroxylase activities in lungs and livers were 1.1 ± 1.0 (P < 0.01) and 113 ± 24 (P < 0.01) units, respectively. The inhibition of benzpyrene hydroxylase activity was apparently mediated either by diminished synthesis or increased catabolism of the enzyme, inasmuch as nickel carbonyl did not have any direct effect upon benzpyrene hydroxylase activity, in vivo or in vitro. It is suggested that by inhibiting benzpyrene hydroxylation, nickel carbonyl may prolong the tissue retention of 3,4-benzpyrene and thereby promote carcinogenesis.

1 This investigation was supported by U. S. Atomic Energy Commission Grant No. AT-(40-1)-3461, by American Cancer Society Grant No. E-374A, and by a USPHS research grant from the National Cancer Institute, No. CA-08783-01.

Received 9/19/66. Accepted 1/ 5/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1967 by the American Association for Cancer Research.